Secondary Logo

Journal Logo

Articles by John S. Bradley

Safety and Efficacy of Ceftazidime–Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial

Bradley, John S.; Roilides, Emmanuel; Broadhurst, Helen; More

The Pediatric Infectious Disease Journal. 38(9):920-928, September 2019.

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial

Bradley, John S.; Broadhurst, Helen; Cheng, Karen; More

The Pediatric Infectious Disease Journal. 38(8):816-824, August 2019.

Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection

Bradley, John S.; Ang, Jocelyn Y.; Arrieta, Antonio C.; More

The Pediatric Infectious Disease Journal. 37(11):1130-1136, November 2018.

Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia

Arrieta, Antonio C.; Bradley, John S.; Popejoy, Myra W.; More

The Pediatric Infectious Disease Journal. 37(9):893-900, September 2018.

An Observational Study of Severe Pertussis in 100 Infants ≤120 Days of Age

Cherry, James D.; Wendorf, Kristen; Bregman, Brooke; More

The Pediatric Infectious Disease Journal. 37(3):202-205, March 2018.

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age

Gonzalez, Daniel; Bradley, John S.; Blumer, Jeffrey; More

The Pediatric Infectious Disease Journal. 36(7):645-653, July 2017.

A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection

Korczowski, Bartosz; Antadze, Tinatin; Giorgobiani, Manana; More

The Pediatric Infectious Disease Journal. 35(8):e239-e247, August 2016.

A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia

Blumer, Jeffrey L.; Ghonghadze, Tina; Cannavino, Christopher; More

The Pediatric Infectious Disease Journal. 35(7):760-766, July 2016.

Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure

Cannavino, Christopher R.; Mendes, Rodrigo E.; Sader, Helio S.; More

The Pediatric Infectious Disease Journal. 35(7):813-815, July 2016.

Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia

Cannavino, Christopher R.; Castaneda-Ruiz, Bibiana; Redman, Rebecca; More

The Pediatric Infectious Disease Journal. 34(11):1264-1267, November 2015.

Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine

Kaplan, Sheldon L.; Barson, William J.; Lin, Philana Ling; More

The Pediatric Infectious Disease Journal. 32(3):203-207, March 2013.

Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive Infections

Abdel-Rahman, Susan M.; Chandorkar, Gurudatt; Akins, Ronda L.; More

The Pediatric Infectious Disease Journal. 30(8):712-714, August 2011.

Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age

Kimberlin, David W.; Shalabi, Marwan; Abzug, Mark J.; More

The Pediatric Infectious Disease Journal. 29(3):195-198, March 2010.

Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes

MASON, EDWARD O.; WALD, ELLEN R.; BRADLEY, JOHN S.; More

The Pediatric Infectious Disease Journal. 22(7):623-628, July 2003.

Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics

KAPLAN, SHELDON L.; MASON, EDWARD O. JR.; BARSON, WILLIAM J.; More

The Pediatric Infectious Disease Journal. 20(4):392-396, April 2001.

Show: